Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)

Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)

This post-marketing surveillance (PMS) study is designed to investigate the efficacy and safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.

Inclusion Criteria:

• Subjects who undergo liver transplantation and azathioprine tablet was administered

Exclusion Criteria:

As this is PMS study, there are no exclusion criteria but contraindications are as follows.

• Subjects with hypersensitivity to the ingredients of azathioprine tablet
• Subjects who is pregnant or might be pregnant
• Subjects whose white count is lower than 3000/cubic millimeter